Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma.

Kumar S, Kim YS, Sun NY, Karadimov GI, Liu L, Ishola A, Arakawa Y, Cortez BN, Varghese D, Mendoza A, Kiseljak-Vassiliades K, Wierman ME, Hernandez JM, Hoang CD, Luo X, Lake R, Hewitt SM, Aladjem MI, Pommier Y, Zhang X, McKnight C, Garrison A, Wood S, Holland D, Thomas CJ, Del Rivero J, Roper N

Open source

DOI: 10.1158/2767-9764.crc-26-0581
Published: 2026 Nov 5
Container: Cancer research communications
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0581,
  title = {Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma.},
  author = {Kumar S and Kim YS and Sun NY and Karadimov GI and Liu L and Ishola A and Arakawa Y and Cortez BN and Varghese D and Mendoza A and Kiseljak-Vassiliades K and Wierman ME and Hernandez JM and Hoang CD and Luo X and Lake R and Hewitt SM and Aladjem MI and Pommier Y and Zhang X and McKnight C and Garrison A and Wood S and Holland D and Thomas CJ and Del Rivero J and Roper N},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-26-0581},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0581}
}

RIS

TY  - JOUR
TI  - Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma.
AU  - Kumar S
AU  - Kim YS
AU  - Sun NY
AU  - Karadimov GI
AU  - Liu L
AU  - Ishola A
AU  - Arakawa Y
AU  - Cortez BN
AU  - Varghese D
AU  - Mendoza A
AU  - Kiseljak-Vassiliades K
AU  - Wierman ME
AU  - Hernandez JM
AU  - Hoang CD
AU  - Luo X
AU  - Lake R
AU  - Hewitt SM
AU  - Aladjem MI
AU  - Pommier Y
AU  - Zhang X
AU  - McKnight C
AU  - Garrison A
AU  - Wood S
AU  - Holland D
AU  - Thomas CJ
AU  - Del Rivero J
AU  - Roper N
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-26-0581
UR  - https://doi.org/10.1158/2767-9764.crc-26-0581
ER  -

APA

S, K., YS, K., NY, S., GI, K., L, L., A, I., Y, A., BN, C., D, V., A, M., K, K., ME, W., JM, H., CD, H., X, L., R, L., SM, H., MI, A., Y, P., X, Z., C, M., A, G., S, W., D, H., CJ, T., J, D. R., & N, R. (2026). Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0581

Source records

pubmed · retrieved 2026-11-10T15:06:27.364Z
europe-pmc · retrieved 2026-11-10T15:06:27.385Z